35 related articles for article (PubMed ID: 17986003)
1. Antisense and Functional Nucleic Acids in Rational Drug Development.
Penchovsky R; Georgieva AV; Dyakova V; Traykovska M; Pavlova N
Antibiotics (Basel); 2024 Feb; 13(3):. PubMed ID: 38534656
[TBL] [Abstract][Full Text] [Related]
2. New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.
Patutina OA; Mironova NL; Vlassov VV; Zenkova MA
Acta Naturae; 2009 Jul; 1(2):44-60. PubMed ID: 22649602
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of small molecule human papillomavirus E6 inhibitors.
Malecka KA; Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Murphy ME; Marmorstein R
ACS Chem Biol; 2014 Jul; 9(7):1603-12. PubMed ID: 24854633
[TBL] [Abstract][Full Text] [Related]
4. Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells.
Zhao B; Hu M
Oncol Lett; 2013 Dec; 6(6):1749-1755. PubMed ID: 24843386
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence.
Bravo-Cuellar A; Ortiz-Lazareno PC; Lerma-Diaz JM; Dominguez-Rodriguez JR; Jave-Suarez LF; Aguilar-Lemarroy A; del Toro-Arreola S; de Celis-Carrillo R; Sahagun-Flores JE; de Alba-Garcia JE; Hernandez-Flores G
Mol Cancer; 2010 May; 9():114. PubMed ID: 20482878
[TBL] [Abstract][Full Text] [Related]
6. The biological properties of E6 and E7 oncoproteins from human papillomaviruses.
Ghittoni R; Accardi R; Hasan U; Gheit T; Sylla B; Tommasino M
Virus Genes; 2010 Feb; 40(1):1-13. PubMed ID: 19838783
[TBL] [Abstract][Full Text] [Related]
7. A triplex ribozyme expression system based on a single hairpin ribozyme.
Aquino-Jarquin G; Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
Oligonucleotides; 2008 Sep; 18(3):213-24. PubMed ID: 18707243
[TBL] [Abstract][Full Text] [Related]
8. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
9. Molecular approaches to cervical cancer therapy.
Alvarez-Salas LM; DiPaolo JA
Curr Drug Discov Technol; 2007 Oct; 4(3):208-19. PubMed ID: 17986003
[TBL] [Abstract][Full Text] [Related]
10. Advances in the development of therapeutic nucleic acids against cervical cancer.
DiPaolo JA; Alvarez-Salas LM
Expert Opin Biol Ther; 2004 Aug; 4(8):1251-64. PubMed ID: 15268660
[TBL] [Abstract][Full Text] [Related]
11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
13. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
